Neogen (NEOG) Cash from Investing Activities Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 28.28% |
| Nov 30, 2025 | -20.23% |
| Aug 31, 2025 | 36.48% |
| May 31, 2025 | -5.42% |
| Feb 28, 2025 | 5.43% |
| Nov 30, 2024 | 1.24% |
| Aug 31, 2024 | -16.99% |
| May 31, 2024 | 25.34% |
| Feb 29, 2024 | 6.39% |
| Nov 30, 2023 | 22.29% |
| Aug 31, 2023 | -2.77% |
| May 31, 2023 | 18.21% |
| Feb 28, 2023 | 44.38% |
| Nov 30, 2022 | 50.39% |
| Aug 31, 2022 | 32.26% |
| May 31, 2022 | -42.14% |
| Feb 28, 2022 | 20.76% |
| Nov 30, 2021 | -45.66% |
| Aug 31, 2021 | -45.13% |
| May 31, 2021 | -6.45% |
| Feb 28, 2021 | -36.10% |
| Nov 30, 2020 | 14.53% |
| Aug 31, 2020 | 0.41% |
| May 31, 2020 | -14.52% |
| Feb 29, 2020 | -64.07% |
| Nov 30, 2019 | -1.07% |
| Aug 31, 2019 | -63.12% |
| May 31, 2019 | -39.13% |
| Feb 28, 2019 | -15.06% |
| Nov 30, 2018 | -11.21% |
| Aug 31, 2018 | 15.41% |
| May 31, 2018 | -14.04% |
| Feb 28, 2018 | -7.53% |
| Nov 30, 2017 | -8.48% |
| Aug 31, 2017 | -26.44% |
| May 31, 2017 | 12.53% |
| Feb 28, 2017 | -91.22% |
| Nov 30, 2016 | -21.94% |
| Aug 31, 2016 | 25.09% |
| May 31, 2016 | -34.65% |
| Feb 29, 2016 | -44.64% |
| Nov 30, 2015 | 27.79% |
| Aug 31, 2015 | -23.85% |